Neurogene Inc. appoints Christy Shafer as Chief Commercial Officer and adds Christine Mikail to board

Neurogene Inc. appoints Christy Shafer as Chief Commercial Officer and adds Christine Mikail to board
Neurogene Inc. names new executives

Neurogene Inc. announced two key leadership moves, naming Christy Shafer as Chief Commercial Officer and appointing Christine Mikail to its Board of Directors in addition to her existing roles as President and Chief Financial Officer.

The company stated that these appointments are aimed at strengthening its executive leadership as it advances its strategic initiatives.

Neurogene recently provided a corporate update on its 2025 financial results and developments for its NGN-401 program. The company highlighted ongoing research and development efforts in its latest disclosure. NGN-401 remains a focus as Neurogene advances its strategic plans.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.